Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G
- PMID: 11137213
- DOI: 10.1016/s0198-8859(00)00198-1
Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G
Abstract
The restricted tissue expression of the MHC class Ib molecules HLA-E, HLA-F, and HLA-G has suggested specialized functions and tight transcriptional control of their genes. Transactivation of classical MHC class I genes is mediated by two groups of juxtaposed cis-acting elements, which can be viewed as regulatory modules. The most upstream module consists of the enhancer A and ISRE, and mediates constitutive and cytokine induced expression, whereas the SXY module is important for the constitutive and CIITA-mediated transactivation of MHC class I genes. Nucleotide sequence divergence in these regulatory elements in the promoters of HLA-E, HLA-F, or HLA-G determines their differential responsiveness to NF-kappaB, IRF1, and CIITA-mediated induction. HLA-E is not inducible by NF-kappaB or IRF1, but is responsive to IFN-gamma through an upstream STAT1 binding site. Furthermore, HLA-E is inducible by CIITA through the SXY regulatory module. HLA-F is inducible by NF-kappaB through the kappaB1 site of enhancer A, is responsive to IFN-gamma through the ISRE, and is inducible by CIITA. Both regulatory modules are divergent in HLA-G rendering this gene unresponsive to NF-kappaB, IRF1, and CIITA-mediated induction. This implies a unique regulation of HLA-G transcription amongst the MHC class Ib genes.
Similar articles
-
The regulation of HLA class I expression: is HLA-G the odd one out?Semin Cancer Biol. 1999 Feb;9(1):55-9. doi: 10.1006/scbi.1998.0109. Semin Cancer Biol. 1999. PMID: 10092551 Review.
-
HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes.J Biol Chem. 2002 Oct 18;277(42):39525-31. doi: 10.1074/jbc.M112273200. Epub 2002 Aug 14. J Biol Chem. 2002. PMID: 12183445
-
HLA-G unique promoter region: functional implications.Immunogenetics. 2001 Oct;53(8):617-25. doi: 10.1007/s00251-001-0373-0. Epub 2001 Oct 13. Immunogenetics. 2001. PMID: 11797094 Review.
-
Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.Ann N Y Acad Sci. 2009 Sep;1173:538-44. doi: 10.1111/j.1749-6632.2009.04660.x. Ann N Y Acad Sci. 2009. PMID: 19758196
-
A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta.J Biol Chem. 2001 Mar 2;276(9):6133-9. doi: 10.1074/jbc.M008496200. Epub 2000 Nov 21. J Biol Chem. 2001. PMID: 11087747
Cited by
-
HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives.Front Immunol. 2020 Jul 8;11:1178. doi: 10.3389/fimmu.2020.01178. eCollection 2020. Front Immunol. 2020. PMID: 32733439 Free PMC article. Review.
-
The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells.Front Oncol. 2020 Dec 23;10:597468. doi: 10.3389/fonc.2020.597468. eCollection 2020. Front Oncol. 2020. PMID: 33425752 Free PMC article. Review.
-
A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus.Nat Commun. 2019 Aug 29;10(1):3902. doi: 10.1038/s41467-019-11845-y. Nat Commun. 2019. PMID: 31467281 Free PMC article.
-
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects.J Transl Med. 2024 Feb 3;22(1):130. doi: 10.1186/s12967-024-04938-w. J Transl Med. 2024. PMID: 38310272 Free PMC article. Review.
-
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells.J Clin Invest. 2002 Oct;110(7):983-92. doi: 10.1172/JCI15950. J Clin Invest. 2002. PMID: 12370276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous